Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Not yet recruiting · NCT06648850 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth | Alopecia, Male Pattern, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder, telogen effluvium | Not yet recruiting | Phase 2 / Phase 3 | 2026-04-13 | NCT06648850 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Applied Biology, Inc. | 8 |
| Daniel Alain, Inc. | 6 |
| Follea International Limited | 6 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||